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Abstract
Background: Machado-Joseph disease (MJD), caused by a CAG repeat expansion located in exon10 of the ATXN3 
gene, is now regarded as one of the most common spinocerebellar ataxia (SCA) in the world. The relative frequency of 
MJD among SCA has previously been estimated at about 50% in the Chinese population and has been reported to be 
related to the frequency of large normal alleles in some populations. Taq polymerase has been used for PCR in nearly all 
studies reported previously.
Methods: Normal and expanded alleles of ATXN3 were detected via PCR using LA Taq DNA polymerase (better for GC-
rich sequences) and denaturing polyacrylamide gel electrophoresis in 150 normal individuals and 138 unrelated 
probands from autosomal dominant SCA families. To compare reaction efficiency, 12 MJD patients' expanded alleles 
were amplified with La Taq and Taq polymerase respectively in the same amplifying systems and reaction conditions.
Results: Normal alleles ranged from 12 to 42 CAG repeats. The most common allele contained 14 repeats with a 
frequency of 23.3%, which corroborates previous reports. The frequency of large normal alleles (>27 repeats) was 0.28, 
which was very high relative to previous reports. The frequency of MJD in SCA patients was 72.5%, which was 
significantly higher than those in previous reports about the Chinese and other Asian populations. This frequency was 
one of the highest reported worldwide, with only Portuguese and Brazilian populations exhibiting higher proportions. 
All 12 expanded alleles were amplified in PCR with La Taq polymerase, whereas only 2 expanded alleles were amplified 
with Taq polymerase.
Conclusion: We have first reported the highest relative frequency of MJD in Asia, and we attribute this high frequency 
to a more efficient PCR using LA Taq polymerase and hypothesized that large ANs may act as a reservoir for expanded 
alleles in the Southeastern Chinese population.
Background
Machado-Joseph disease (MJD), also called spinocerebel-
lar ataxia type 3 (SCA3), is associated with a variety of
clinical manifestations, including progressive ataxia, oph-
thalmoplegia, a variable degree of pyramidal signs,
extrapyramidal signs and facial myokymia [1]. MJD was
initially reported in Portuguese-Azorean descendants
and is now regarded as one of the most common spinoc-
erebellar ataxia (SCA) in the world [2,3]. It is caused by a
CAG repeat expansion located in exon10 of the ATXN3
gene on chromosome 14q32.1 [4]. The number of CAG
repeats was first described as 13-36 in normal alleles
(ANs) and 68-79 in expanded alleles. With continued
research and publication of related data, the range of ANs
has broadened to 12-44, and now MJD is usually molecu-
larly diagnosed when the CAG repeat crosses a threshold
of 52 without regard for whether some patients carry
"intermediate alleles" or "reduced penetrance alleles",
such as 45-51[5].
The most common method used to study the expanded
alleles of ATXN3  is to amplify expanded alleles with
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MJD52/MJD25 or MJD52/MJD70 primers [4]. Although
amplifying systems and ion conditions vary across stud-
ies, Taq polymerase was used for PCR in nearly all previ-
ous reports. The efficiency of amplification is affected by
long length and high GC content in the amplified
sequence when using Taq polymerase [6] and it is diffi-
cult to amplify expanded alleles having large CAG repeats
[7]. To alleviate this, here we use the LA Taq polymerase
which is better for amplifying expanded alleles with GC-
rich sequences.
The frequency of MJD in SCA patients differs in differ-
ent population, and some studies [8-15] reported that the
relative frequency of dominant SCA (including MJD) was
related to the frequency of large normal alleles in some
populations. In the present study, we have recruited 150
unrelated healthy individuals and 138 probands from
autosomal dominant SCA families of Southeastern Chi-
nese origin to analyze the distributions and characteris-
tics of CAG repeats of ATXN3, and have found a much
higher frequency (72.5%) of MJD in SCA patients com-
pared to previous reports. In fact, this relative frequency
is only slightly less than that reported in the Portuguese
and Brazilian populations (84.2%) [16,17]. We have attrib-
uted this high relative frequency to better detection of
expanded alleles via more efficient PCR using LA Taq
polymerase and hypothesized that large ANs may act as a
reservoir for expanded alleles in the Southeastern Chi-
nese population.
Methods
Subjects
One hundred and fifty unrelated healthy individuals and
138 unrelated probands from autosomal dominant SCA
families were recruited from the Southeastern Chinese
population (figure 1) between July 9, 2003 and June 31,
2009. Patients were clinically diagnosed in accordance
with the previously published standard [18]. Each patient
was given detailed clinical and neurological examinations
by two experienced neurologists and a clinical history
was obtained. Informed consent was obtained from each
subject (if <18 years of age, consent was obtained from
their legal guardians) and the protocol was approved by
the ethical committee. Genomic DNA was extracted
from peripheral EDTA blood via the salt precipitation
method [19] or with a QIAamp DNA Blood Minikit
(QIAGEN, Hilden, Germany).
Molecular analysis
The CAG repeat expansion located in exon 10 of ATXN3
was amplified using MJD52/MJD25 primers as described
in the previous report [4]. The PCR amplification was
performed in a total volume of 25 μL containing 0.10 μg
of genomic DNA, 0.10 μmol/L of each primer, 50 μmol/L
of each dNTP and 1.25 units of LA Taq polymerase with
12.5 μL 2× GC buffer I (TaKaRa, Chiba, Japan). PCR
products were generated using a Mini-Cycler PCR system
(Applied Biosystems, Foster City, CA, USA). After an ini-
tial denaturation for 2 minutes at 94°C, the PCR reaction
included 30 cycles of denaturation at 94°C for 30 seconds,
annealing at 58°C for 45 seconds and extension at 72°C
for 1 minute, followed by a final extension at 72°C for 5
minutes. PCR products were separated by an 8% poly-
acrylamide gel that was run at 27 V/cm at 55°C for 3
hours. The pGEM-3Zf (+) DNA-Hae III marker was used
as a DNA size marker and the gel was silver stained to
visualize the bands. Based on the marker size (bp) and the
transport ratio of the DNA marker in the gel, we used a
statistical package (version 11.0, SPSS, Chicago, IL) to
generate a curve with the equation Y = aXb (Y indicated
the size of fragments of PCR products, X indicated the
transport ratio of fragments of PCR products, a and b
indicated coefficient and exponent that all generated by
the statistical package, respectively) to estimate size of
PCR products. The estimated number of CAG repeats =
(size of fragments of PCR products- 161bp)/3. The num-
bers of CAG repeats of all subjects were estimated in this
wa y a t  fir s t.  T o  verify  a c cura cy of  CA G  n um be rs  es t i-
mated, 10 normal alleles which were estimated to contain
14 CAG repeats and all expanded alleles were further
confirmed by sequencing. The PCR products were elec-
trophoresed on a 2.5% agarose gel and separated bands
were excised. The DNA contained in excised bands was
purified from the gel using the Geneclean II Kit (Qbio-
gene, Carlsbad, CA, USA). The purified product was
sequenced using the procedure which has been described
elsewhere [20].
Figure 1 Distribution of the SCA families in the present study. The 
numbers in parentheses indicate numbers of MJD families/numbers of 
SCA families. (Reproduced with permission from http://nfgis.ns-
di.gov.cn)Gan et al. BMC Medical Genetics 2010, 11:47
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To compare the efficiency of amplification using La Taq
and Taq polymerase, 12 MJD patients' expanded alleles
which were confirmed by PCR using La Taq polymerase
were amplified with Taq polymerase in the same amplify-
ing systems and reaction conditions mentioned above
except that LA Taq polymerase with 12.5 μL 2× GC buf-
fer I was displaced by Taq polymerase with 2.5 μL 10×
buffer (Dichuan Inc, Shanghai, China). The PCR prod-
ucts amplified with Taq and La Taq polymerase were all
electrophoresed on 2.5% agarose gel. The DL2000 (Tian-
gen, Bejing, China) was used as a DNA size marker.
Statistical analysis
All statistical analyses were performed using SPSS soft-
ware version 11.0 (SPSS, Chicago, IL). The mean, median,
variance and skewness were determined for the distribu-
tions of ANs. In accordance with the previous report[9],
the alleles carrying more than 27 CAG repeats (>27
repeats) were defined as large ANs. Chi-square tests were
used to analyse the difference between present study and
other studies both in the frequency of the large ANs and
the relative prevalence of MJD. The results were consid-
ered statistically significant at p < 0.05.
Results
Analysis of CAG repeats in normal individuals
Twenty-seven alleles with the heterozygosity of 0.78 were
identified in 150 normal individuals. The distribution of
the 27 alleles is shown in figure 2. The number of CAG
repeats ranged from 12 to 42. The three most frequent
alleles had 14 (23.3%), 13 (16.3%) and 28 (10.6%) CAG
repeats. The mean, median, variance and skewness were
20.8, 19.0, 56.0 and 0.42, respectively. The polyacrylamide
gel electrophoresis analysis is shown in figure 3A and the
results for the individual who was carrying homozygous
for an allele which was estimated to contain 14 CAG
repeats was confirmed by sequencing (figure. 4A). The
difference in the frequency of large ANs between the
present study and other studies involving Japanese [9],
Indian [10], Czech [11] populations and a combined pop-
ulation comprised of Acadian, Black, Caucasian, Inuit
and Thai [21] is shown in table 1.
Figure 2 Distribution of the CAG repeats in 300 ANs from 150 
healthy Chinese individuals. The numbers upon the column indi-
cate the number of allele.
Figure 3 The polyacrylamide gel electrophoresis analysis of ANs 
(A) and alleles of SCA patients (B). In figure 2A, lanes 1-5 were normal 
individuals. The black line indicates the upper limit of ANs. In figure 2B, 
lanes 1, 3, 4, and 5 were MJD patients; lane 2 was an SCA patient, but 
not a MJD patient. The black line indicates the place of the lower limit 
of expanded alleles. M: pGEM-3Zf (+) DNA-Hae III marker.
Figure 4 Chromatograms of the AN with 14 CAG (A) and the ex-
panded allele with 81 CAG (B).G
a
n
 
e
t
 
a
l
.
 
B
M
C
 
M
e
d
i
c
a
l
 
G
e
n
e
t
i
c
s
 
2
0
1
0
,
 
1
1
:
4
7
h
t
t
p
:
/
/
w
w
w
.
b
i
o
m
e
d
c
e
n
t
r
a
l
.
c
o
m
/
1
4
7
1
-
2
3
5
0
/
1
1
/
4
7
P
a
g
e
 
4
 
o
f
 
9
Table 1: The frequencies of large normal alleles of ATXN3 gene
Number 
of CAG 
repeats
Present 
study
Japanese Indian Czech Combined Population
Frequency Frequency χ2 PF r e q u e n c y χ2 PF r e q u e n c y χ2 PF r e q u e n c y χ2 P
>27 0.28 0.21 3.683 0.055 0.12 42.045 0.000 0.09 27.663 0.000 0.17 8.616 0.003
>28 0.19 0.11 6.788 0.009 0.08 29.060 0.000 0.04 21.956 0.000 0.11 10.341 0.001
>29 0.13 0.07 5.869 0.015 0.04 28.517 0.000 0.04 11.836 0.001 0.08 5.264 0.002
>30 0.10 0.05 4.342 0.037 0.03 22.329 0.000 0.03 8.499 0.004 0.07 3.192 0.074
>31 0.07 0.05 1.332 0.248 0.02 14.120 0.000 0.01 8.186 0.004 0.05 2.190 0.139Gan et al. BMC Medical Genetics 2010, 11:47
http://www.biomedcentral.com/1471-2350/11/47
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Analysis of MJD expanded alleles
One hundred out of 138 probands were identified as hav-
ing one expanded allele (>60 repeats), with the numbers
of repeats varying from 68 to 84. Thus, the frequency of
MJD in 138 SCA families was 72.5% (100/138), which is
significantly higher than those reported in other Asian
populations (table 2) and is quite high worldwide, being
lower only than the Portuguese and Brazilian populations
(table 3). In the other 38 probands with no expanded
allele, 6 of them were homozygous for normal alleles and
need to be further studied by other techniques. The poly-
acrylamide gel electrophoresis analysis is shown in figure
3B and the chromatogram of an expanded allele with 81
CAG repeats is shown in figure 4B.
The agarose gel electrophoresis analysis of alleles of 12
MJD patients is shown in figure 5. All normal alleles were
able to be amplified in PCR with La Taq or Taq poly-
merase. However, reaction efficiency was different for
expanded alleles. All 12 and only 2 expaneded alleles were
able to be amplified in PCR with La Taq polymerase (fig-
ure. 5B) and Taq polymerase (figure. 5A), respectively, for
the same 12 MJD patients.
Discussion
In the present study, we have analyzed the characteristics
of CAG repeats of ATXN3  in 300 chromosomes of
healthy Chinese individuals and found that the CAG
repeat number ranged from 12 to 42. The most common
allele contained 14 CAG repeats, which was also the most
common allele found in the studies of Limprasert et al
[21] and T akano et al [9]. The frequency of large ANs
Table 2: Frequencies of MJD in SCA patients from different Asia populations
Number of MJD Number of SCA Frequency (%) P Reference
Present study 100 138 72.5
Chinese mainland 59 120 49.2 <0.001 23
41 85 48.2 <0.001 24
26 75 34.7 <0.001 25
1 8 12.5 <0.001 22
Chinese Taiwan 35 74 47.3 <0.001 26
26 81 32.1 <0.001 27
Singapore 15 36 41.7 0.001 28
Japan 87 202 43.1 <0.001 9
12 29 41.4 0.001 29
91 330 27.6 <0.001 30
30 113 26.5 <0.001 31
35 143 24.5 <0.001 32
28 117 23.9 <0.001 33
8 46 17.4 <0.001 34
3 86 3.5 <0.001 35
Thailand 35 182# 19.2 <0.001 36
Korea 4 40 10.0 <0.001 37
13 237 5.5 <0.001 38
India 5 14 35.7 0.005 39
15 105 14.3 <0.001 40
2 39 5.1 <0.001 12
7 143 4.9 <0.001 10
1 32 3.1 <0.001 41
2 77 2.6 <0.001 42
0 28 0 <0.001 43
# composed of patients with dominant SCA and sporadic ataxiaGan et al. BMC Medical Genetics 2010, 11:47
http://www.biomedcentral.com/1471-2350/11/47
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(>27 repeats) was 0.28, which is higher than the fre-
quency in previously studied populations [9-11,21].
The frequency of MJD in the 138 SCA families involved
in our study was 72.5%, which is, as far as we know, the
highest rate in Asia based on studies of the Chinese main-
land individuals [22-25], Chinese Taiwanese [26,27], Sin-
gaporean [28], Japanese [9,29-35], Thais[36] Korean
[37,38] and Indian [10,12,39-43]. Moreover, it is one of
the highest worldwide, with only Portuguese and Brazil-
ian populations exhibiting higher proportions
[11,13,16,17,44-56]. We presume that there are two possi-
bilities why the relative prevalence of MJD is so high in
the present study.
The first reason is that the frequency of large ANs in
the present study is very high. Some studies [8-15] sug-
gest that the frequency of normal ANs with a relatively
large number of CAG repeats is related to the prevalence
of the dominant SCA (including MJD), since the large
ANs share the same haplotypes as those of expanded
alleles and therefore might act as a reservoir for expanded
alleles. However, some other studies reported the preva-
lence of MJD is not an indirect reflection of the frequency
of large normal alleles in Portuguese [57,58]. Here, the
frequencies of large ANs are significantly higher than in
related data reported by Limprasert et al [21] in >27, >28,
and >29 repeats, Takano et al [9] in >28, >29, and >30
repeats, Chattopadhyay et al [10] and Bauer et al [11] in
>27, >28, >29, >30, and >31 repeats. In fact, the relative
frequency of MJD in the present study was the highest of
any published data other than those from Portugal and
Brazil, and was significantly higher than in the study of
Takano et al [9], Chattopadhyay et al [10] and Bauer et al
[11]. As such, the high frequency of large ANs associated
with such a high relative frequency of MJD suggests that
in this population large ANs may constitute a reservoir
from which the expanded alleles may be emerging.
Our use of LA Taq polymerase to amplify alleles of SCA
patients is another possible reason for the result. Arezi et
al [6] reported that the efficiency of amplification using
Taq polymerase was decreased with an increase in ampli-
con length and GC content, and the reason for the
decrease may be related to the enzyme's lack of proof-
reading activity. Thus, it is difficult to amplify expanded
alleles (GC-rich) and sometimes it is impossible to
amplify expanded alleles when expanded alleles have a
large quantity of CAG repeats [7]. We amplified
expanded alleles of the same 12 MJD patients with Taq
polymerase and LA Taq polymerase respectively and
Table 3: Frequencies of MJD in SCA patients from various countries
Countries Number of MJD Number of SCA Frequency (%) Reference
Portugal 32 38 84.2 16
Brazil 96 114 84.2 17
Present study 100 138 72.5
Portugal/Brazil 67 106 63.2 44
Germany 32 77 41.6 45
France 25 87 28.7 46
Holland 64 227 28.2 47
America* 31 149 20.8 48
Spain 11 72 15.3 49
Australia 11 88 12.5 13
Mexico 13 108 12.0 50
South Africa 2 54 3.7 51
Italy 2 183 1.1 52
UK 0 22 0 53
Serbia 0 38 0 54
Finland 0 49 0 55
Norway 0 19 0 56
Czech 0 118# 01 1
Combined 486 1687 28.8
*The patient subjects mixed with African American, Caucasian American, Cambodian, Japanese, Pakistani, Lebanese and Peruvian; # 
composed of patients with dominant SCA and sporadic ataxiaGan et al. BMC Medical Genetics 2010, 11:47
http://www.biomedcentral.com/1471-2350/11/47
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found most expanded alleles were non-amplified in PCR
with Taq polymerase whereas all expanded alleles were
amplified in PCR with LA Taq polymerase (figure. 5). For
all the normal alleles that were amplified in PCR with Taq
polymerase, it was possible that there were false negative
results in molecular testing of MJD. The relative fre-
quency of MJD in the present study is significantly higher
than in the previous studies that also investigated Chi-
nese SCA patients [22-28]. Notably, in these previous
studies, the expanded alleles were amplified using Taq
polymerase rather than LA Taq polymerase. Therefore, it
may be better to use DNA polymerases that are better at
a m p l i f y i n g  G C - r i c h  s e q u e n c e s ,  s u c h  a s  L A  T a q ,  w h e n
amplifying the alleles of SCA patients. Additionally, 6 out
of the 38 probands with no expanded allele were homozy-
gous for normal alleles. It is possible that these results are
false negative results because of either extremely large
r e p e a t  s i z e  o r  t h e  p r e s e n c e  o f  p o l y m o r p h i s m s  i n  t h e
primer-annealing regions [7]. Therefore we need to apply
to other techniques such as Southern blot to exclude this
possibility of false negative results in further study. How-
ever, no matter whatever the results of this further study
show, the high relative frequency of MJD in the present
study is not affected.
In addition, Martins et al [59] concluded that MJD
might first occur in Asia and extend to Europe later,
reaching its high prevalence in Portuguese due to founder
effect. The high prevalence of MJD (19.2 per 100,000
i n h a b i t a n ts )  r e s t r i ct ed  t o  t h e  Gose i  a r e a  o f  T o ya m a  i n
Japan [60] may support this conclusion [59]. Therefore
we suppose that possible Asian origin of MJD and
founder effect may also contribute to the high relative fre-
quency of MJD in the present study.
Conclusion
We have reported the characteristics of CAG repeats in
ATXN3 in a normal Chinese population and in patients
with SCA. We found the highest relative frequency of
MJD observed in Asian SCA patients. The results sup-
port the hypothesis that in this population large ANs may
constitute a reservoir from which the expanded alleles
may be emerging. Furthermore, LA Taq polymerase was
proven to be more efficient than Taq polymerase in the
amplification of the expanded alleles, facilitating and
improving the molecular diagnosis.
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